Brief: Herantis Pharma Says Contemplating Carrying Out A Directed Share Issue And Rights Issue

Herantis Pharma Oyj

29/03/2022 17:51

March 29 (Reuters) - Herantis Pharma Oyj  HRTIS.HE :
    * HERANTIS PHARMA PLC IS CONTEMPLATING CARRYING OUT A
DIRECTED
SHARE ISSUE AND A RIGHTS ISSUE
    * HERANTIS PHARMA PLC IS CONTEMPLATING TWO SEPARATE SHARE
ISSUES
WITH A PRELIMINARY AGGREGATE AMOUNT OF UP TO EUR 8.7 MILLION
    * HERANTIS PHARMA -FIRST SHARE ISSUE WOULD BE DIRECTED SHARE
ISSUE
TO INVESTORS IN WHICH CO WOULD OFFER SHARES FOR TARGETED AMOUNT
OF ABOUT EUR 1.4 MILLION
    * HERANTIS  - SECOND SHARE ISSUE WOULD BE A RIGHTS ISSUE
("RIGHTS
ISSUE") OF PRELIMINARY UP TO EUR 7.3 MILLION AND WOULD TAKE
PLACE AFTER DIRECTED ISSUE
    * SECOND SHARE ISSUE TO BE AT A SUBSCRIPTION PRICE OF EUR
1.5 PER
SHARE


 ((Reuters.Briefs@thomsonreuters.com;))